Published: 3 July 2019
Author(s): Guillaume Bayer, Marie-Sara Agier, Bertrand Lioger, Marion Lepelley, Marie Zenut, Mary-Christine Lanoue, François Maillot, Annie-Pierre Jonville-Bera
Issue: July 2019
Section: Original Article

Rituximab induced serum sickness (RISS) is a rare delayed hypersensitivity reaction. The aim of this study was to describe the epidemiological and clinical characteristics of the RISS cases reported in France.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.